As Johnson & Johnson (JNJ) Share Price Declined, Holder Chicago Equity Partners LLC Lowered Its Holding by $3.94 Million

July 12, 2018 - By Kristen Paramore

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Principal Grp Inc has invested 0.7% in Johnson & Johnson (NYSE:JNJ). Cohen Cap Mgmt invested 1.71% of its portfolio in Johnson & Johnson (NYSE:JNJ). Intrust Fincl Bank Na holds 29,319 shares. Paloma Mgmt Company has 8,507 shares for 0.02% of their portfolio. The New York-based Allsquare Wealth Mngmt Lc has invested 0.68% in Johnson & Johnson (NYSE:JNJ). Ibm Retirement Fund holds 62,982 shares or 1.49% of its portfolio. Cheviot Value Management accumulated 6.82% or 102,271 shares. Hayek Kallen invested in 3.5% or 39,391 shares. Brick Kyle Assocs has 2.42% invested in Johnson & Johnson (NYSE:JNJ) for 23,336 shares. 43,579 are held by Regal Inv Advisors Ltd Liability Company. Hollow Brook Wealth Mgmt Lc owns 4.03% invested in Johnson & Johnson (NYSE:JNJ) for 39,243 shares. Catalyst Cap Lc reported 0.07% of its portfolio in Johnson & Johnson (NYSE:JNJ). The Massachusetts-based Aureus Asset Mgmt Ltd Liability Co has invested 0.59% in Johnson & Johnson (NYSE:JNJ). Hudson Valley Inv Advsr Adv accumulated 73,977 shares. Albion Grp Ut holds 0.53% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 26,898 shares.

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity.

Chicago Equity Partners Llc decreased its stake in Johnson & Johnson (JNJ) by 9.45% based on its latest 2018Q1 regulatory filing with the SEC. Chicago Equity Partners Llc sold 30,800 shares as the company’s stock declined 8.03% with the market. The institutional investor held 295,086 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $37.82 million, down from 325,886 at the end of the previous reported quarter. Chicago Equity Partners Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $338.60B market cap company. The stock decreased 0.89% or $1.14 during the last trading session, reaching $126.24. About 4.83M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since July 12, 2017 and is downtrending. It has underperformed by 17.32% the S&P500.

Chicago Equity Partners Llc, which manages about $10.49 billion and $3.13 billion US Long portfolio, upped its stake in Us Foods Hldg Corp by 114,115 shares to 258,120 shares, valued at $8.46 million in 2018Q1, according to the filing. It also increased its holding in S&P Global Inc by 21,005 shares in the quarter, for a total of 70,775 shares, and has risen its stake in Pfizer Inc (NYSE:PFE).

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17 before the open. They expect $2.06 earnings per share, up 12.57 % or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53 billion for 15.32 P/E if the $2.06 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

More news for Johnson & Johnson (NYSE:JNJ) were recently published by:, which released: “Buy Johnson & Johnson” on June 20, 2018.‘s article titled: “Premarket analyst action – healthcare” and published on July 12, 2018 is yet another important article.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 10 analysts covering Johnson & Johnson (NYSE:JNJ), 5 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. Johnson & Johnson has $170.0 highest and $110.0 lowest target. $141.89’s average target is 12.40% above currents $126.24 stock price. Johnson & Johnson had 18 analyst reports since January 16, 2018 according to SRatingsIntel. The rating was maintained by Leerink Swann on Wednesday, April 18 with “Buy”. Credit Suisse maintained it with “Outperform” rating and $151 target in Friday, April 20 report. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Monday, February 26 with “Buy” rating. On Wednesday, April 18 the stock rating was maintained by Deutsche Bank with “Buy”. On Tuesday, April 10 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The rating was maintained by Jefferies with “Buy” on Friday, April 13. Credit Suisse maintained the stock with “Buy” rating in Tuesday, June 12 report. Citigroup maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, February 27. Citigroup has “Neutral” rating and $146 target. Wells Fargo maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, February 6. Wells Fargo has “Buy” rating and $160.0 target. The stock has “Buy” rating by Leerink Swann on Thursday, May 17.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: